SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
VRXA

Veraxa Biotech AG - Post de-SPAC (NASDAQ:VRXA)

DE · Delayed Price · Currency is USD
Also listed: VACHHealthcare · Biotechnology
$1.04+$0.01 (+0.97%)
 
Market cap
$147M
Insider Score
Listed since
Jun 9, 2026
Website
Market Cap$147.06M-91.5%
Revenue (ttm)n/a
Net Incomen/a
EPSn/a
Shares Out141.41M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume114,628
Open$1.03
Previous Close$1.03
Day's Range$1.03 - $1.06
52-Week Range$0.90 - $27.36
Beta0.26
Analystsn/a
Price Targetn/a
Earnings Daten/a
+1.94% (1D)
No price history available.

About VRXA

Veraxa Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment. The company develops antibody-based therapeutics, including antibody-drug conjugates and bispecific antibody formats, and offers a proprietary technology platform for functional antibody screening and bioconjugation. Its product pipeline includes drug candidates such as ADCs and BITACs, with some in clinical development, and it provides partnership models for collaborative development from target identification to antibody and ADC creation. The company was founded in 2021 and is based in Heidelberg, Germany.

Address
Im Neuenheimer Feld 584, Heidelberg, ZH, 69120, DE
Market Cap
147 million
Employees
8
Industrial Classification
Biotechnology

Veraxa Biotech AG - Post de-SPAC Stock Analysis — InsiderScore

Insider Score
See top-rated InsiderScore stocks ›
88th Percentile Overall Score
VRXA InsiderScore:91 / 99

Veraxa Biotech AG - Post de-SPAC scored higher than 88% of companies evaluated by InsiderBuying, and ranked 10th out of 103 stocks in the biotech sector.

Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.

Dollars Committed

Insiders at Veraxa Biotech AG - Post de-SPAC bought $125.3K of stock across 5 purchases in the last 90 days, the largest of them $75.0K.

Stake Increase

The average purchase added about 89% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.

New Positions

2 of these purchases were made by someone who held no stock at all beforehand — going from nothing to a position is the strongest form of this signal.

This category carries 35% of the Insider Score.

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$125.33K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day
+0.97%
5 Days
-3.70%
1 Month
-1.89%
6 Months
-90.11%
1 Year
-91.51%

$VRXA stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in VRXA holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by VRXA's directors and management

Net Shares Purchased by Insiders−60k−30k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

VRXA Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New VRXA patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to VRXA from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from VRXA’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
100% of score
83.73
Analyst Ratings
No data yet
—
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
5
Sells
0
Buy Value
$125.33K
Distinct Buyers
4

Insider Score Trend Over Time

+24.2 since Sep 23
0255075100Sep 23 — Insider Score 65.4Sep 24 — Insider Score 64.5Sep 25 — Insider Score 79.6Sep 26 — Insider Score 79.5Sep 27 — Insider Score 79.7Sep 28 — Insider Score 80.0Sep 29 — Insider Score 79.4Sep 30 — Insider Score 79.2Oct 1 — Insider Score 78.4Oct 2 — Insider Score 44.0Oct 3 — Insider Score 78.2Oct 4 — Insider Score 78.3Oct 5 — Insider Score 78.3Oct 6 — Insider Score 77.5Oct 7 — Insider Score 77.2Oct 8 — Insider Score 77.0Oct 9 — Insider Score 76.9Oct 10 — Insider Score 76.3Oct 11 — Insider Score 77.2Oct 12 — Insider Score 77.3Oct 13 — Insider Score 77.0Oct 14 — Insider Score 76.6Oct 15 — Insider Score 76.6Oct 16 — Insider Score 76.1Oct 17 — Insider Score 76.0Oct 18 — Insider Score 76.3Oct 19 — Insider Score 76.0Oct 20 — Insider Score 76.0Oct 21 — Insider Score 75.8Oct 22 — Insider Score 75.8Oct 23 — Insider Score 75.9Oct 24 — Insider Score 75.8Oct 25 — Insider Score 75.5Oct 26 — Insider Score 75.4Oct 27 — Insider Score 75.4Oct 28 — Insider Score 75.3Oct 29 — Insider Score 74.7Oct 30 — Insider Score 94.5Oct 31 — Insider Score 94.5Nov 1 — Insider Score 96.7Nov 2 — Insider Score 96.6Nov 3 — Insider Score 96.5Nov 4 — Insider Score 96.3Nov 5 — Insider Score 95.9Nov 6 — Insider Score 95.6Nov 7 — Insider Score 95.6Nov 8 — Insider Score 95.6Nov 9 — Insider Score 95.7Nov 10 — Insider Score 95.6Nov 11 — Insider Score 95.3Nov 12 — Insider Score 95.0Nov 13 — Insider Score 94.4Nov 14 — Insider Score 93.9Nov 15 — Insider Score 94.1Nov 16 — Insider Score 93.8Nov 17 — Insider Score 93.3Nov 18 — Insider Score 92.1Nov 19 — Insider Score 91.1Nov 20 — Insider Score 90.5Nov 21 — Insider Score 89.6Sep 23Oct 22Nov 21

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.